Alprazolam Dosing
For anxiety disorders, start alprazolam at 0.25-0.5 mg three times daily, with a maximum of 4 mg/day in divided doses; for panic disorder, initiate at 0.5 mg three times daily and titrate up to 1-10 mg/day (typically 5-6 mg/day) as needed. 1
Standard Dosing for Anxiety Disorders
Initial dose: 0.25-0.5 mg orally three times daily 1
Titration: Increase at 3-4 day intervals to achieve therapeutic effect 1
Maximum dose: 4 mg/day in divided doses 1
The FDA label is clear that dosing should be distributed evenly throughout waking hours on a three or four times daily schedule to minimize interdose symptoms 1. While some guidelines mention alprazolam for anticipatory nausea/vomiting in cancer patients at 0.25-0.5 mg three times daily 2, the primary FDA-approved indication remains anxiety and panic disorders.
Panic Disorder Dosing
Initial dose: 0.5 mg three times daily 1
Titration strategy:
- Increase at 3-4 day intervals in increments of no more than 1 mg/day 1
- Slower titration above 4 mg/day is advisable 1
- Mean effective dose in clinical trials: 5-6 mg/day 1
- Dose range in controlled trials: 1-10 mg/day 1
Clinical evidence: Research demonstrates that 70% of patients with plasma levels >20 ng/mL achieved complete panic attack remission versus only 31% with levels <20 ng/mL 3. A fixed-dose study showed both 2 mg and 6 mg daily doses were superior to placebo, though many patients respond adequately to less than 6 mg/day 4.
Special Population Dosing
Elderly Patients (>65 years)
Starting dose: 0.25 mg given 2-3 times daily 2, 1
Maximum initial dose: 0.25 mg 2-3 times daily 1
The elderly are especially sensitive to benzodiazepine effects 2, 1. One guideline for managing anxiety in elderly/debilitated patients recommends a maximum of 2 mg in 24 hours 5. The FDA label explicitly states elderly patients may require dose reduction if side effects occur even at the recommended starting dose 1.
Hepatic Impairment
Advanced liver disease: 0.25 mg given 2-3 times daily 2, 1
Severe hepatic impairment: Maximum 2 mg/day 6
Alprazolam clearance is significantly reduced in cirrhosis 7, necessitating lower starting doses and cautious titration.
Debilitating Disease
Starting dose: 0.25 mg orally 2-3 times daily 2, 1
This conservative approach applies to any patient with significant comorbidities that may increase sensitivity to benzodiazepines.
Discontinuation Protocol
Never abruptly discontinue alprazolam due to withdrawal risk and potential seizures 1.
Recommended taper:
- Decrease by no more than 0.5 mg every 3 days 1
- Some patients require even slower reduction 1
- If withdrawal symptoms develop, return to previous dose and stabilize before attempting slower taper 1
A controlled discontinuation study found that a slower taper schedule reduced withdrawal syndrome symptoms, though both fast and slow tapers achieved similar rates of complete discontinuation 1.
Critical Dosing Considerations
Dose-response relationship: Steady-state plasma concentrations increase by approximately 10-12 mcg/L for each 1 mg/day increase in dose 7. Pharmacokinetics are dose-independent up to at least 9 mg/day 8.
Therapeutic monitoring: While not routinely necessary, plasma levels of 20-40 mcg/L correlate with optimal anxiety reduction in panic disorder 7, 3. Higher concentrations may be needed for complete panic attack suppression but increase side effect risk 3.
Common pitfall: Physicians often under-dose panic disorder patients. Clinical trials used mean doses of 5-6 mg/day, with some patients requiring up to 10 mg/day for adequate response 1. However, start low and titrate carefully, as side effects increase with dose 8, 3.
Drug interactions: Cimetidine, fluoxetine, fluvoxamine, and propoxyphene significantly impair alprazolam clearance and require dose reduction 7.